The Tokyo Medical Affairs Leadership Summit held in September 2017 brought together Medical Affairs leaders from a range of pharmaceutical and biotechnology companies to discuss challenges and opportunities as Medical Affairs evolves to become a more strategic scientific partner within their organizations. Summit discussion focused on four areas:
- The Value of the Medical Affairs Organization
- Medical Affairs Strategy Planning
- The Role and Value of the Medical Science Liaison
- Preparing for the Future With Real World Evidence
As in prior years, the Summit provided a forum for Medical Affairs leaders to share perspectives on their most pressing challenges, learn about best practices and exchange strategies for achieving great success.
